Skip to main content
SpringerLink
Log in

Colonization and infection with fluoroquinolone-resistantEscherichia coli among cancer patients: Clonal analysis

  • Clinical and Epidemiological Studies
  • Originalia
  • Published:
Infection Aims and scope Submit manuscript

Summary

Escherichia coli with high-level fluoroquinolone resistance were isolated from feces and/or various body sites of 16 cancer patients who were on oral fluoroquinolone prophylaxis. Population analysis of fecal isolates in 11 patients showed that fluoroquinoloneresistantE. coli was the only aerobic gram-negative bacillus present and exhibited a relatively homogenous fluoroquinolone MIC distribution. Molecular typing by pulsed field gel electrophoresis of chromosomal DNA digests or by random amplified polymorphic DNA fingerprinting confirmed the clonal nature of gastrointestinal tract colonization withE. coli. Genotyping of ten colonies picked from the same fecal culture demonstrated identical strains in four of four patients examined. Identical genotypes from the same patient were isolated over prolonged periods of time in 12 of 12 cases examined, with one patient (with the longest follow-up of 14 months) who lost his initial genotype and became persistently colonized with a new genotype. In the 11 patients who developed infection due to fluoroquinolone-resistantE. coli, molecular typing also indicated that fecal colonization was associated with, and presumably preceded infection due to an indistinguishable genotype of fluoroquinolone-resistantE. coli.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cruciani, M., Cruciani, M., Rampazzo, R., Malena, M., Lazzarini, L., Todeschini, G., Messori, A., Concia, E.: Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Clin. Infect. Dis. 23 (1996) 795–805.

    Google Scholar 

  2. Engels, E., Lau, J., Barza, M.: Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. J. Clin. Oncol. 16 (1998) 1179–1187.

    CAS  PubMed  Google Scholar 

  3. Carratalá, J., Fernandez-Sevilla, A., Tubau, F., Dominguez, M. A., Gudiol, F.: Emergence of fluoroquinolone-resistantEscherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrob. Agents Chemother. 40 (1996) 503–505.

    Google Scholar 

  4. Cometta, A., Calandra, T., Bille, J., Glauser, M. P.:Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia (letter). N. Engl. J. Med. 330 (1994) 1240–1241.

    Article  CAS  PubMed  Google Scholar 

  5. Kern, W. V., Andriof, E., Oethinger, M., Kern, P., Hacker, J., Marre, R.: Emergence of fluoroquinolone-resistantEscherichia coli at a cancer center. Antimicrob. Agents Chemother. 38 (1994) 681–687.

    CAS  PubMed  Google Scholar 

  6. Oethinger, M., Conrad, S., Kaifel, K., Cometta, A., Bille, J., Klotz, G. Glauser, M. P., Marre, R., Kern, W. V.: Molecular epidemiology of fluoroquinolone-resistantEscherichia coli bloodstream isolates from patients admitted to European cancer centers. Antimicrob. Agents Chemother. 40 (1996) 387–392.

    Google Scholar 

  7. Arbeit, R. D., Arthur, M., Dunn, R., Kim C., Selander, R. K., Goldstein, R.: Resolution of recent evolutionary divergence amongEscherichia coli from related lineages: the application of pulsed field electrophoresis to molecular epidemiology. J. Infect. Dis. 161 (1990) 230–235.

    CAS  PubMed  Google Scholar 

  8. Gray, L. D.:Escherichia, Salmonella, Shigella, andYersinia. In:Murray, P., Baron, E. J., Pfaller, M. A., Tenover, F. C., Yolken, R. H. (eds.): Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington DC 1995, pp. 450–458.

    Google Scholar 

  9. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 2nd ed., approved standard M7-A2. Villanova, PA, NCCLS, 1990.

    Google Scholar 

  10. Berg, D. E., Akopyants, N. S., Kersulyte, D.: Fingerprinting microbial genomes using the RAPD or AP-PCR method. Methods. Mol. Cell Biol. 5 (1994) 13–24.

    CAS  Google Scholar 

  11. Wang, G., Whittam, T. S., Berg, C. M., Berg, D. E.: RAPD (arbitrary primer) PCR is more sensitive than multilocus enzyme electrophoresis for distinguishing related bacterial strains. Nucleic Acids Res. 21 (1993) 5930–5933.

    Article  CAS  PubMed  Google Scholar 

  12. Wendt, C. Hollis, R., Pfaller, M., Wenzel, R., Herwaldt, L.: Molecular epidemiology of bacteremia due toEscherichia coli. Abstracts 7th European Congress of Clinical Microbiology and Infectious Diseases, 1995, abstr. 1106.

  13. Lindin-Janson, G., Kaijser, B., Lincoln, K., Olling, S., Wedel, H.: The homogeneity of the fecal coliform flora of normal schoolgirld, characterized by serological and biochemical properties. Med. Microbiol. Immunol. 164 (1978) 247–253.

    Article  Google Scholar 

  14. Brumfitt, W., Franklin, I., Grady, D., Hamilton-Miller, J. M. T., Iliffe, A.: Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob. Agents Chemother. 26 (1984) 757–761.

    CAS  PubMed  Google Scholar 

  15. Pecquet, S., Andrémont, A., Tancrède, C.: Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora. Antimicrob. Agents Chemother. 29 (1986) 1047–1052.

    CAS  Google Scholar 

  16. Pecquet, S., Andrémont, A., Tancrède, C.: Effect of oral ofloxacin on fecal bacteria in human volunteers. Antimicrob. Agents Chemother. 31 (1987) 124–125.

    CAS  PubMed  Google Scholar 

  17. Henning, K. J., Delencastre, H., Eagan, J., Boone, N., Brown, A., Chung, M., Wollner, N., Armstrong, D.: Vancomycin-resistantEnterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical shedding. Ped. Infect. Dis. J. 15 (1996) 848–854.

    Article  Google Scholar 

  18. Knapp, J. S., Fox, K. K., Trees, D. L., Whittington, W. L.: Fluoroquinolone resistance inNeisseria gonorrhoeae. Emerging Infect. Dis. 3 (1997) 33–39.

    Article  CAS  PubMed  Google Scholar 

  19. Karch, H., Russmann, H., Schmidt, H., Schwarzkopf, A., Heesemann, J.: Long-term shedding and clonal turnover of enterohemorrhagicEscherichia coli O157 in diarrheal diseases. J. Clin. Microbiol. 33 (1995) 1602–1605.

    CAS  PubMed  Google Scholar 

  20. Caugant, D. A., Levin, B. R., Selander, R. K.: Genetic diversity and temporal variation ofEcherichia coli in a human host. Genetics 98 (1981) 467–490.

    CAS  PubMed  Google Scholar 

  21. Piddock, L. J. V.: Mechanisms of resistance to fluoroquinolones: state-of-the-art 1992–1994. Drugs 49 (1995) (Suppl 2): 29–35.

    Article  CAS  PubMed  Google Scholar 

  22. Heisig, P., Tschorny, R.: Characterization of fluoroquinolone-resistant mutants ofEscherichia coli selectedin vitro. Antimicrob. Agents Chemother. 38 (1994) 1284–1291.

    CAS  PubMed  Google Scholar 

  23. Piddock, L. J. V., Hall, M. C., Walters, R. N.: Phenotypic characterization of quinolone-resistant mutants ofEnterobacteriaceae selected from wild-type,gyrA type and multiply-resistant (marA) type strains. J. Antimicrob. Chemother. 28 (1991) 185–198.

    Article  CAS  PubMed  Google Scholar 

  24. van Kraaij, M. G. J., Dekker, A. W., Peters, E., Fluit, A. Verdonck, L. F., Rozenberg-Arska, M.: Emergence and complications of ciprofloxacin-resistantEscherichia coli in hematological cancer patients. Program and Abstracts of the 9th International Symposium on Infections in the Immunocompromised Host, 1996, abstr. 034.

  25. Kern, W. V., Conrad, S., Oethinger, M., Hay, B., Trautmann, M., Kern, P., Marre, R.: Clinical and molecular epidemiology of fluoroquinolone-resistantEscherichia coli isolated from cancer patients: an update. Program and Abstracts of the 9th International Symposium on Infections in the Immunocompromised Host, Assisi, 1996, abstr. 17.

  26. Leigh, D. A., Walsh, B., Hancock, P., Travers, G.: Pharmacokinetics of ofloxacin and the effect on the faecal flora of healthy volunteers. J. Antimicrob. Chemother. 22 (1988) (Suppl C) 115–125.

    CAS  PubMed  Google Scholar 

  27. van Saene, J. J. M., van Saene, H. K. F., Leck, C. F.: Inactivation of quinolones by faeces. J. Infect. Dis. 153 (1986) 998–1000.

    Google Scholar 

  28. Ball, P.: Is resistantE. coli bacteremia an inevitable outcome for neutropenic patients receiving a fluoroquinolone as prophylaxis? (editorial) Clin. Infect. Dis. 20 (1995) 561–563.

    Google Scholar 

  29. Murphy, M., Brown, A. E., Sepkowitz, K. A., Bernard, E. M., Kiehn, T. E., Armstrong, D.: Fluoroquinolone prophylaxis for the prevention of bacterial infection in patients with cancer—is it justified? Clin. Infect. Dis. 25 (1997) 346–347.

    Article  CAS  PubMed  Google Scholar 

  30. Kern, W. V.: Epidemiology of fluoroquinolone-resistantEscherichia coli among neutropenic patients. Clin. Infect. Dis. 27 (1998) 235–237.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Laboratoriumsmedizin und Transfusionsmedizin, D-32545, Bad Oeynhausen

    M. Oethinger

  2. Sektion Infektiologie und Klinische Immunologie, Medizinische Universitätsklinik und Poliklinik, D-89070, Ulm

    A. S. Jellen-Ritter & W. V. Kern

  3. Institut für Mikrobiologie und Immunologie, Universitätsklinikum, D-89070, Ulm, Germany

    S. Conrad & R. Marre

Authors
  1. M. Oethinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. S. Jellen-Ritter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Conrad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Marre
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. V. Kern
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oethinger, M., Jellen-Ritter, A.S., Conrad, S. et al. Colonization and infection with fluoroquinolone-resistantEscherichia coli among cancer patients: Clonal analysis. Infection 26, 379–384 (1998). https://doi.org/10.1007/BF02770840

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02770840

Keywords

Search

Navigation